[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

How Local Florida Clinical Trials Are Furthering Research and How to Join Them

How Local Florida Clinical Trials Are Furthering Research and How to Join Them image

How Local Florida Clinical Trials Are Furthering Research and How to Join Them

Webinar
event Mar 28, 2023 / 06:30PM - 08:00PM EDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Dr. Dickran Kazandjian joins the Florida Chapter in Myeloma Awareness Month to share why clinical trials are so important, what different types of clinical trials exist, and which ones are openly recruiting in your local area. Come with your questions!

Schedule & Agenda

The panelist Audrey Burton-Bethke
6:30 PM
Introductions
Audrey Burton-Bethke

Audrey introduces the agenda of the event and our featured speaker Dr. Dickran Kazandjian.

Event panelist Audience
6:35 PM
Member Spotlight
Audience
The panelist Dickran Kazandjian, MD
6:45 PM
Presentation
Dickran Kazandjian, MD

Dr. Dickran Kazandjian shares why clinical trials are so important, what different types of clinical trials exist, and which ones are openly recruiting in your local area. 

Event panelist Audience
7:15 PM
Questions and Answers
Audience

Type your questions in the chat and we will answer them! 

Event panelist Audience
7:25 PM
Announcements and Post Meeting Mingle
Audience

Speakers & Moderators

The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio
The panelist Dickran Kazandjian, MD
Dickran Kazandjian, MD

Dr. Kazandjian’s clinical and translational research interests lie in the treatment of precursor plasma cell disorders including high risk smoldering multiple myeloma and the role of immunotherapy in plasma cell dyscrasias. In addition, he is re-evaluating the role of autologous stem cell transplant (ASCT) in the era of highly efficacious novel-novel drugs, immunotherapy biologics, and cell-based therapies with the hypothesis that certain subsets of patients with myeloma may not benefit by default upfront ASCT.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Adaptive logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Follicular lymphoma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.